#United States #Stamford #Daybreak #Synchrony #CareCredit

Synchrony and Daybreak: A New Era in Sleep Health

As sleep disorders become increasingly prevalent, a groundbreaking partnership between Synchrony and Daybreak is aimed at revolutionizing how Americans approach their sleep health. Synchrony, a renowned consumer financial services firm, has collaborated with Daybreak, a leading provider of at-home sleep testing kits and devices, to offer flexible financing options for consumers seeking to improve their sleep.

Understanding Sleep Disorders

With estimates suggesting that 50 to 70 million Americans suffer from sleep disorders, including sleep apnea, the need for accessible and effective diagnostic solutions has never been more pressing. Daybreak provides at-home sleep testing solutions that not only diagnose sleep issues but also offer alternatives to traditional Continuous Positive Airway Pressure (CPAP) devices.

Claude Royster, Vice President and General Manager of Wellness at Synchrony, emphasized the significance of quality sleep. He said, "The evidence increasingly points to quality sleep being a pillar of good health. Unfortunately, achieving consistent, restful sleep may not be possible for people who are unknowingly living with a sleep disorder."

The Role of CareCredit

Through this partnership, Daybreak products can now be financed using CareCredit, a health and wellness credit card, which is a crucial step in making these vital services accessible to a broader audience. Poor sleep hygiene is linked to significant health issues, such as memory loss, mood swings, and weakened immune response, highlighting the importance of seeking help for sleep disorders.

Erin Gadhavi, Senior Vice President and General Manager of Wellness at Synchrony, remarked, "This collaboration showcases our ongoing commitment to helping consumers pursue their health and wellness goals." By allowing customers to finance their sleep health solutions effectively, the partnership aims to reduce the financial barriers that often prevent individuals from seeking necessary care.

The Daybreak Sleep System

Daybreak offers an FDA-cleared, custom-fit oral device known as the "Daybreak Sleep System," which has shown promising results in reducing symptoms like snoring and hypopnea from the very first night of use. This product enables users to address their sleep problems conveniently from the comfort of their homes, without the need for extensive in-lab testing that can incur hefty expenses.

The collaboration officially began in July 2024 and is set to last for three years, culminating in March 2027. Daybreak's CEO, Van Morgan, expressed excitement about the financial assistance provided by CareCredit, stating that it would empower more individuals to seek necessary sleep solutions without the burden of high out-of-pocket costs.

Towards Better Sleep for All

As part of their broader strategy, Synchrony continues to seek partnerships that enhance access to health and wellness products. Their financing options aim to cater to various consumer needs, ensuring that improving sleep health becomes an achievable goal for a wider demographic.

Daybreak exemplifies innovation in sleep health, transforming how individuals engage with their sleep-related challenges. With a dedicated team of sleep medicine experts and an evidence-based approach, Daybreak is on a mission to reshape the treatment of sleep apnea, ultimately aiming for a healthier future for millions of Americans.

For those interested in exploring these sleep solutions further, visit the Daybreak website or consult a healthcare provider. With the support of Synchrony and Daybreak, better sleep health is now within reach for countless individuals searching for relief from their sleep struggles.